Novel AAV Capsids for Intravitreal Delivery: Identifying and Characterizing Novel AAV Variants in Non-Human Primates

被引：0
|
作者：
Guerin, Karen [1 ]
Geller, Scott [2 ]
Flannery, John G. [2 ]
Isacoff, Ehud [2 ]
Beltran, William A. [3 ]
Byrne, Leah C. [4 ]
Ozturk, Bilge E. [4 ]
Mozayeni, Cyrus [1 ]
机构：
[1] Vedere Bio II, R&D, Cambridge, MA USA
[2] Univ Calif Berkeley, Mol & Cell Biol, Berkeley, CA 94720 USA
[3] Univ Penn, Div Expt Retinal Therapies, Philadelphia, PA 19104 USA
[4] Univ Pittsburgh, Ophthalmol, Philadelphia, PA USA
来源：
MOLECULAR THERAPY | 2022年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1199
引用
收藏
页码：557 / 557
页数：1
相关论文
共 50 条
  • [21] Therapeutic Factor VIII Expression After AAV Delivery in Non-Human Primates
    Anguela, Xavier M.
    Elkouby, Liron
    Toso, Raffaella
    DiPietro, Marti
    Davidson, Robert J.
    High, Katherine A.
    Sabatino, Denise E.
    MOLECULAR THERAPY, 2016, 24 : S23 - S23
  • [22] Cochlear transduction via cerebrospinal fluid delivery of AAV in non-human primates
    Ranum, Paul T.
    Tecedor, Luis
    Keiser, Megan S.
    Chen, Yong Hong
    Leib, David E.
    Liu, Xueyuan
    Davidson, Beverly L.
    MOLECULAR THERAPY, 2023, 31 (03) : 609 - 612
  • [23] Evaluation of AAV Variants for Transgene Expression and Distribution in Rabbits and Non-Human Primate Eyes Following Intravitreal Delivery
    Iglesias, Bibiana Veronica
    Woodburn, Kathryn W.
    Cao, Jingtai
    Wiegand, Stanley J.
    Keravala, Annahita
    Romano, Carmelo
    Gasmi, Mehdi
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [24] A Promising New Family of Peptide-Modified AAV Capsids for Gene Delivery to the Central Nervous System in Non-Human Primates
    Chan, Ken Y.
    Pacouret, Simon
    Huang, Qin
    Zheng, Qingxia
    Vandenburg, Charles
    Wu, Jason
    Brauer, Pamela
    Zhang, Qiangge
    Tobey, Isabelle
    Wu, Carolyn
    Chen, Albert T.
    Kozareva, Velina
    Feng, Guoping
    Deverman, Benjamin E.
    MOLECULAR THERAPY, 2022, 30 (04) : 556 - 556
  • [25] Rationally Engineered Novel AAV Capsids for Intraarticular Gene Delivery
    Li, Wenjun
    Samulski, R. Jude
    Li, Chengwen
    MOLECULAR THERAPY, 2023, 31 (04) : 651 - 652
  • [26] Comparative analysis of tropism of a large pool of AAV capsids in cell culture, mice, and non-human primates
    Mercer, A. C.
    Giles, A. R.
    Yost, S. A.
    Firnberg, E.
    Cho, S.
    Tejada, S.
    Egley, J.
    Smith, J.
    Janczura, K.
    Karumuthil-Melethil, S.
    Danos, O.
    Liu, Y.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A31 - A31
  • [27] Para-Retinal Administration of AAV204, a Novel AAV Capsid for the Treatment of Inherited Retinal Dystrophies, in Non-Human Primates
    Kevany, Brian
    Kerns, Scott
    Padegimas, Linas
    MOLECULAR THERAPY, 2022, 30 (04) : 436 - 437
  • [28] Quality control and quality assurance of novel AAV vectors for gene transfer studies in non-human primates
    Hammill, DM
    Calcedo, R
    Qin, QY
    Sanmiguel, J
    Gallery, L
    Gao, GP
    Wilson, JM
    MOLECULAR THERAPY, 2003, 7 (05) : S346 - S347
  • [29] AAV204, a Novel AAV Capsid, Demonstrates Superior Macular Transduction Following Para-Retinal Administration in Non-human Primates
    Kevany, Brian
    Kerns, Scott
    Padegimas, Linas
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [30] Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates
    S J Gray
    S Nagabhushan Kalburgi
    T J McCown
    R Jude Samulski
    Gene Therapy, 2013, 20 : 450 - 459
12345